REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ranbaxy (Malaysia) Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ranbaxy (Malaysia) Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ranbaxy (Malaysia) Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Kuala Lumpur. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on August 26, 1982. The company’s latest financial report indicates a net sales revenue increase of 17.08% in 2024. Its’ total assets recorded a growth of 16.73%. Ranbaxy (Malaysia) Sdn. Bhd.’s net profit margin increased by 3.59% in 2024.

Headquarters
Unit 21-13, Level 21, Q Sentral, 2A Jalan Stesen Sentral 2, Kuala Lumpur Sentral
Kuala Lumpur; Federal Territories; Postal Code: 50470

Contact Details: Purchase the Ranbaxy (Malaysia) Sdn. Bhd. report to view the information.

Website: http://www.sunpharma.com

Basic Information
Registered Capital:
Purchase the Ranbaxy (Malaysia) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Ranbaxy (Malaysia) Sdn. Bhd. report to view the information.
Incorporation Date:
August 26, 1982
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
56.24%
Purchase this report to view the information.
39.87%
Purchase this report to view the information.
1.88%
Purchase this report to view the information.
1.43%
Purchase this report to view the information.
0.15%
Company Performance
Financial values in the chart are available after Ranbaxy (Malaysia) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
17.08%▲
Total operating revenue
17.08%▲
Operating profit (EBIT)
46.12%▲
EBITDA
58.26%▲
Net Profit (Loss) for the Period
48.6%▲
Total assets
16.73%▲
Total equity
28.85%▲
Operating Profit Margin (ROS)
4.34%▲
Net Profit Margin
3.59%▲
Return on Equity (ROE)
2.98%▲
Debt to Equity Ratio
-0.3%▼
Quick Ratio
2.75%▲
Cash Ratio
1.9%▲

Similar companies

Pharmaniaga Berhad
 
Vance Bioenergy Sdn. Bhd.
Igb Berhad
 
Caring Pharmacy Group Berhad
Apex Healthcare Bhd
 
Duopharma Biotech Berhad
Reckitt Benckiser (Malaysia) Sdn. Bhd.
 
Duopharma Manufacturing (Bangi) Sdn. Bhd.
Hoe Pharmaceuticals Sdn. Bhd.
 
Hpa Industries Sdn. Bhd.
Smith & Nephew Operations Sdn. Bhd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo